Oncology & Cancer

Researchers expanding the types of cancer CAR-T therapy can target

Teaching the body's immune cells to recognize and fight cancer is one of the holy grails in medicine. Over the past two decades, researchers have developed new immunotherapy drugs that stimulate a patient's immune cells to ...

Diabetes

A new target for diabetes treatment

In her synthetic biology lab, Karmella Haynes focuses much of her effort on developing better ways of exploring how human body cells work – or don't work like they should. She'll be applying her expertise in that area to ...

Medical research

Building 'smart' cell-based therapies

A Northwestern University synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other sites of disease.

Oncology & Cancer

Synthetic biology approaches to improving immunotherapy

The AACR 2018 Meeting in Chicago is ending today and has featured the major new results in cancer treatment and immunotherapy treatments in particular. Immunotherapy, the use of the patient's own immune system to attack their ...

page 2 from 6